Form 4 Filing for Beam Therapeutics Inc.

This filing details a Form 4 submission for Beam Therapeutics Inc. (BEAM) concerning the reporting owner John Maraganore. On June 3, 2026, Mr. Maraganore was granted an option to acquire 19,676 shares of Common Stock at a price of $0.00 per share, with a post-transaction ownership of 19,676 shares. The option has an exercise price of $29.55 and an expiration date of June 3, 2036. The option vests in full on the earlier of the first anniversary of the grant date or immediately prior to the next annual stockholders' meeting, contingent upon continued service to the board. This transaction is classified as an acquisition of a derivative security.